Stay updated on LUPUZOR Clinical Trial
Sign up to get notified when there's something new on the LUPUZOR Clinical Trial page.

Latest updates to the LUPUZOR Clinical Trial page
- Check5 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision indicator changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe completed Phase 3 LUPUZOR study record is displayed, with details on its treatment arms, outcome measures, participant criteria, study locations, and supporting documents.SummaryDifference57%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedA site-wide NIH banner announces the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1. The page otherwise remains a 403 Forbidden error screen.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details. The header and footer remain visible, but the study information is blocked.SummaryDifference18%

Stay in the know with updates to LUPUZOR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LUPUZOR Clinical Trial page.